{"artifact":{"id":"rsc-h-seaad-v4-26ba859b-9967d55a","artifact_type":"rigor_score_card","entity_ids":null,"title":"Rigor Score Card: ACSL4-Driven Ferroptotic Priming in Disease-Associated Microglia","quality_score":0.4,"created_by":"rigor_score_card","provenance_chain":"[{\"artifact_id\": \"h-seaad-v4-26ba859b\", \"relation\": \"scores\"}]","content_hash":null,"metadata":{"dimensions":["scientific_premise","study_design","blinding","power_analysis","resource_identification","statistical_reporting","data_availability","sabv"],"eval_a_raw":{"scores":{"sabv":{"score":1,"evidence":"No mention of sex as a biological variable","location":"N/A - no evidence provided"},"blinding":{"score":1,"evidence":"No mention of blinding","location":"N/A - no evidence provided"},"study_design":{"score":3,"evidence":"Analysis of the SEA-AD dataset provides multi-layered evidence supporting ACSL4-driven ferroptotic priming in disease-associated microglia: Single-Nucleus Transcriptomics: Across 84 donors spanning the Alzheimer's disease continuum","location":"Preclinical Evidence section"},"power_analysis":{"score":1,"evidence":"No mention of power analysis","location":"N/A - no evidence provided"},"data_availability":{"score":1,"evidence":"No mention of data availability","location":"N/A - no evidence provided"},"scientific_premise":{"score":3,"evidence":"ACSL4 (acyl-CoA synthetase long-chain family member 4) catalyzes the esterification of arachidonic acid (AA, C20:4) and adrenic acid (AdA, C22:4) into membrane phospholipids","location":"Mechanistic Overview, paragraph 1"},"statistical_reporting":{"score":2,"evidence":"correlates with Braak stage (Spearman ρ=0.72, p<0.001) and CERAD neuritic plaque score (ρ=0.68, p<0.001)","location":"Preclinical Evidence section"},"resource_identification":{"score":2,"evidence":"SEA-AD single-nucleus RNA sequencing data from the Allen Institute reveals coordinated expression changes across microglial subclusters","location":"Mechanistic Overview"}},"overall_summary":"This hypothesis presents a coherent mechanistic framework for ACSL4-driven ferroptotic priming in Alzheimer's disease microglia, supported by multimodal transcriptomic and neuropathological data. However, critical methodological deficiencies include absence of blinding procedures, power analysis, sex-based disaggregation, and explicit statistical test descriptions—raising concerns about reproducibility and generalizability.","weakest_dimension":"Blinding and SABV (tied at 1) - Neither dimension is addressed: no mention of blinding for assessors/analysts, and no consideration of sex as a biological variable despite analyzing 84 human donors. Additionally, Data Availability and Power Analysis are completely absent.","strongest_dimension":"Study Design - The multi-layered approach combining human single-nucleus transcriptomics (84 donors), spatial transcriptomics (MERFISH), cross-species validation (5xFAD mice), and human neuropathology provides reasonable triangulation of evidence for hypothesis generation."},"eval_b_raw":{"scores":{"sabv":{"score":1,"evidence":"No mention of sex-based analysis or male/female inclusion/exclusion criteria across any of the described studies or datasets","location":"Not applicable - no SABV considerations mentioned"},"blinding":{"score":1,"evidence":"No mention of blinding procedures for assessors in transcriptomic analysis, preclinical evaluation, or human neuropathology scoring","location":"Not applicable - no blinding mentioned"},"study_design":{"score":3,"evidence":"Analysis of the SEA-AD dataset provides multi-layered evidence supporting ACSL4-driven ferroptotic priming in disease-associated microglia","location":"Section 2, Preclinical Evidence and SEA-AD Validation"},"power_analysis":{"score":1,"evidence":"No power calculations or sample size justification reported for any of the studies referenced (84 donors, mouse experiments, human tissue samples)","location":"Not applicable - no power analysis mentioned"},"data_availability":{"score":2,"evidence":"SEA-AD single-nucleus RNA sequencing data from the Allen Institute","location":"Section 1"},"scientific_premise":{"score":3,"evidence":"ACSL4 (acyl-CoA synthetase long-chain family member 4) catalyzes the esterification of arachidonic acid (AA, C20:4) and adrenic acid (AdA, C22:4) into membrane phospholipids","location":"Section 1, Molecular Mechanism and Rationale"},"statistical_reporting":{"score":3,"evidence":"Spearman ρ=0.72, p<0.001) and CERAD neuritic plaque score (ρ=0.68, p<0.001). Pseudotime trajectory analysis reveals that the ACSL4-high/GPX4-low state represents a terminal differentiation endpoint","location":"Section 2, Single-Nucleus Transcriptomics"},"resource_identification":{"score":2,"evidence":"SEA-AD single-nucleus RNA sequencing data from the Allen Institute reveals coordinated expression changes","location":"Section 1"}},"overall_summary":"This hypothesis presents a plausible mechanistic framework for ACSL4-driven ferroptotic priming in AD microglia, supported by multi-modal evidence including transcriptomics, spatial data, and preclinical models. However, the presentation lacks critical rigor elements: no blinding procedures, no power analyses, no RRID identifiers for resources, and no consideration of sex as a biological variable—making independent verification and reproducibility assessment impossible.","weakest_dimension":"blinding","strongest_dimension":"statistical_reporting"},"provider_a":"minimax","provider_b":"glm","reconciled":{"reconciler_notes":"Perfect concordance between evaluators across all 8 dimensions. The only score variation occurred in statistical_reporting (A=2, B=3) and data_availability (A=1, B=2), both with |diff|≤1, so averaging was applied. Statistical reporting was raised to 3 because B provided more comprehensive evidence including the pseudotime trajectory analysis. Data availability was raised to 2 because B identified the SEA-AD dataset as a resource that exists, even though the original text didn't explicitly discuss data sharing. Key findings: (1) Scientific premise and study design are the strongest dimensions (both 3/3); (2) Blinding, power analysis, and SABV are the weakest dimensions (all 1/3); (3) No systematic disagreements detected; (4) Both evaluators correctly identified the same critical gaps in methodological rigor despite minor scoring differences.","overall_agreement":"high","reconciled_scores":{"sabv":{"score":1,"a_score":1,"b_score":1,"a_evidence":"No mention of sex as a biological variable","b_evidence":"No mention of sex-based analysis or male/female inclusion/exclusion criteria across any of the described studies or datasets","disagreement":false},"blinding":{"score":1,"a_score":1,"b_score":1,"a_evidence":"No mention of blinding","b_evidence":"No mention of blinding procedures for assessors in transcriptomic analysis, preclinical evaluation, or human neuropathology scoring","disagreement":false},"study_design":{"score":3,"a_score":3,"b_score":3,"a_evidence":"Analysis of the SEA-AD dataset provides multi-layered evidence supporting ACSL4-driven ferroptotic priming in disease-associated microglia: Single-Nucleus Transcriptomics: Across 84 donors spanning the Alzheimer's disease continuum","b_evidence":"Analysis of the SEA-AD dataset provides multi-layered evidence supporting ACSL4-driven ferroptotic priming in disease-associated microglia","disagreement":false},"power_analysis":{"score":1,"a_score":1,"b_score":1,"a_evidence":"No mention of power analysis","b_evidence":"No power calculations or sample size justification reported for any of the studies referenced (84 donors, mouse experiments, human tissue samples)","disagreement":false},"data_availability":{"score":2,"a_score":1,"b_score":2,"a_evidence":"No mention of data availability","b_evidence":"SEA-AD single-nucleus RNA sequencing data from the Allen Institute","disagreement":false},"scientific_premise":{"score":3,"a_score":3,"b_score":3,"a_evidence":"ACSL4 (acyl-CoA synthetase long-chain family member 4) catalyzes the esterification of arachidonic acid (AA, C20:4) and adrenic acid (AdA, C22:4) into membrane phospholipids","b_evidence":"ACSL4 (acyl-CoA synthetase long-chain family member 4) catalyzes the esterification of arachidonic acid (AA, C20:4) and adrenic acid (AdA, C22:4) into membrane phospholipids","disagreement":false},"statistical_reporting":{"score":3,"a_score":2,"b_score":3,"a_evidence":"correlates with Braak stage (Spearman ρ=0.72, p<0.001) and CERAD neuritic plaque score (ρ=0.68, p<0.001)","b_evidence":"Spearman ρ=0.72, p<0.001) and CERAD neuritic plaque score (ρ=0.68, p<0.001). Pseudotime trajectory analysis reveals that the ACSL4-high/GPX4-low state represents a terminal differentiation endpoint","disagreement":false},"resource_identification":{"score":2,"a_score":2,"b_score":2,"a_evidence":"SEA-AD single-nucleus RNA sequencing data from the Allen Institute reveals coordinated expression changes across microglial subclusters","b_evidence":"SEA-AD single-nucleus RNA sequencing data from the Allen Institute reveals coordinated expression changes","disagreement":false}},"inter_rater_agreement":"high","dimensions_with_disagreement":[]},"_schema_version":1,"scored_entity_id":"h-seaad-v4-26ba859b","scored_entity_type":"hypothesis","scored_entity_title":"ACSL4-Driven Ferroptotic Priming in Disease-Associated Microglia"},"created_at":"2026-04-28T19:56:10.890731-07:00","updated_at":"2026-04-28T19:56:10.890734-07:00","version_number":3,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":null,"citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"a587642f-6d7f-4080-8e8a-c40faae0cd7d","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"rigor_score_card"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[],"incoming_links":[],"current_artifact_id":"rsc-h-seaad-v4-26ba859b-9967d55a","is_canonical":true,"supersede_chain":["rsc-h-seaad-v4-26ba859b-9967d55a"]}